Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Hasford

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Expert Opinion on Drug Safety|September 24, 2020
Impact of the COVID-19 pandemic on clinical trials with drugsJoerg Hasford
BMJ (Clinical Research Ed.)|February 8, 2013
New European Union regulation of clinical trials puts trial participants at riskJoerg Hasford
BMJ (Clinical Research Ed.)|November 8, 2013
Use long acting β2 agonists only when asthma cannot be controlled otherwiseJoerg Hasford
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 23, 2017
[The impact of the EU Regulation 536/2014 on the tasks and functioning of ethics committees in Germany]Joerg Hasford
Medizinische Monatsschrift Fur Pharmazeuten|September 13, 2002
[Can patent rights be an obstacle? Various views from clinical studies]Joerg Hasford
Medizinische Monatsschrift Fur Pharmazeuten|August 1, 2002
[Chance or exploitation? Clinical studies from various views]Joerg Hasford
The Journal of Infectious Diseases|August 27, 2020
Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 VaccinesJoerg Hasford
Medizinische Monatsschrift Fur Pharmazeuten|January 14, 2003
[Publication of clinical studies. CONSORT statement]Joerg Hasford
Haematologica|September 2, 2014
Remission status should not be treated as a base-line covariate--reply to Etienne et alMichael Lauseker, Joerg Hasford
BMC Medical Ethics|October 29, 2020
Redundant trials can be prevented, if the EU clinical trial regulation is applied dulyDaria Kim, Joerg Hasford
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Safety|September 24, 2020
Impact of the COVID-19 pandemic on clinical trials with drugsJoerg Hasford
BMJ (Clinical Research Ed.)|February 8, 2013
New European Union regulation of clinical trials puts trial participants at riskJoerg Hasford
BMJ (Clinical Research Ed.)|November 8, 2013
Use long acting β2 agonists only when asthma cannot be controlled otherwiseJoerg Hasford
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 23, 2017
[The impact of the EU Regulation 536/2014 on the tasks and functioning of ethics committees in Germany]Joerg Hasford
Medizinische Monatsschrift Fur Pharmazeuten|September 13, 2002
[Can patent rights be an obstacle? Various views from clinical studies]Joerg Hasford
Medizinische Monatsschrift Fur Pharmazeuten|August 1, 2002
[Chance or exploitation? Clinical studies from various views]Joerg Hasford
The Journal of Infectious Diseases|August 27, 2020
Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 VaccinesJoerg Hasford
Medizinische Monatsschrift Fur Pharmazeuten|January 14, 2003
[Publication of clinical studies. CONSORT statement]Joerg Hasford
Haematologica|September 2, 2014
Remission status should not be treated as a base-line covariate--reply to Etienne et alMichael Lauseker, Joerg Hasford
BMC Medical Ethics|October 29, 2020
Redundant trials can be prevented, if the EU clinical trial regulation is applied dulyDaria Kim, Joerg Hasford
Pageof 11